Scher, H. I., Fizazi, K., Saad, F., Chi, K. N., Taplin, M.-E., Sternberg, C. N., … De Bono, J. S. (2013). Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 31). Orlando, FL: AMER SOC CLINICAL ONCOLOGY. https://doi.org/10.1200/jco.2013.31.6_suppl.6

Scher, Howard I., Karim Fizazi, Fred Saad, Kim N. Chi, Mary-Ellen Taplin, Cora N. Sternberg, Andrew J. Armstrong, Mohammad Hirmand, David Forer, and Johann Sebastian De Bono. “Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013. https://doi.org/10.1200/jco.2013.31.6_suppl.6.

Scher HI, Fizazi K, Saad F, Chi KN, Taplin M-E, Sternberg CN, et al. Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2013.

Scher, Howard I., et al. “Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor.” JOURNAL OF CLINICAL ONCOLOGY, vol. 31, no. 6, AMER SOC CLINICAL ONCOLOGY, 2013. Wos, doi:10.1200/jco.2013.31.6_suppl.6.

Scher HI, Fizazi K, Saad F, Chi KN, Taplin M-E, Sternberg CN, Armstrong AJ, Hirmand M, Forer D, De Bono JS. Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2013.